AP521 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT1A receptor, 5-HT1A receptor, 5-HT1B receptor, 5-HT1B receptor, 5-HT1D receptor, 5-HT5A receptor, and 5-HT7 receptor.
Molecular Weight
402.89
Molecular Formula
C20H19ClN2O3S
Targets
5-HT1A receptor: 94 nM (IC50, in human); 5-HT1A receptor: 135 nM (IC50, in rat); 5-HT1B receptor: 254 nM (IC50, in rat); 5-HT1B receptor: 5530 nM (IC50, in human); 5-HT1D receptor: 418 nM (IC50, in human); 5-HT5A receptor: 422 nM (IC50, in human); 5-HT7 receptor: 198 nM (IC50, in rat)
Form
Lyophilized powder
Purity
>98%
Applications
AP521 can be used for its potent anxiolytic-like effects.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
